PRESS RELEASE ERYTECH announces the availability of the exemption document relating to the proposed combination with Pherecydes Lyon , May 23, 2023 - ERYTECH Pharma , a clinical-stage. | May 23, 2023
▪Entry into a definitive merger agreement between ERYTECH and PHERECYDES ▪Completion of a contribution in kind of PHERECYDES shares to ERYTECH . | May 16, 2023
Entry into a definitive merger agreement between PHERECYDES and ERYTECH Combination with ERYTECH to be submitted to shareholders' vote on June 23, 2023 Completion of a contribution in
PARIS, FRANCE/ ACCESSWIRE / May 16, 2023 / Akkadian Partners SA ("Akkadian") has announced that Akkadian Partners Fund, a Luxemburg registered securitisation fund under its management, now holds over a
ERYTECH Provides Update on the Announced Combination with PHERECYDES Entry into a definitive merger agreement between ERYTECH and PHERECYDESCompletion of a contribution in kind of PHERECYDES